CEACAM1 and steatosis: Deleting CEACAM1 exclusively in hepatocytes (as in AlbCre+Cc1fl/fl mice) impaired hepatic insulin clearance at 2–3 months of age, followed by hyperinsulinemia-driven hepatic insulin resistance and steatosis at ~6 months of age.